Launch week offerEnds in00h00m00s

Benedicte Leynaert

Researcher

INSERM
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (16)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Background Few population‐based studies have described allergic rhinitis (AR) according to the Allergic Rhinitis and its Impact on Asthma (ARIA) classification, and none have assessed the impact of asthma on this classification. Our aims were to 1) describe AR according to four ARIA classes and 2) within each of the four ARIA classes, compare participants with AR alone versus those with AR and asthma. Methods Cross‐sectional analyses were performed using data from the 2014 annual follow‐up questionnaire of the French adult population‐based cohort Constances. Current AR was defined by the report of sneezing, runny, or blocked nose in the last 12 months and the report of nasal allergies. Following ARIA recommendations, rhinitis was classified according to its severity (mild or moderate‐severe) and duration (intermittent or persistent). Ever asthma was also defined by a questionnaire. Results Among the 4675 participants with AR (57% women, mean age 50.2 ± 12.7 years), 44% were classified as mild/intermittent, 16% mild/persistent, 25% moderate‐severe/intermittent, and 15% moderate‐severe/persistent. Within each of the four ARIA classes, compared to participants with rhinitis alone, participants with rhinitis and asthma had significantly more severe symptoms, more conjunctivitis, a higher mean eosinophil count and more treatments with intra‐nasal corticosteroids and oral antihistamines co‐medication. Conclusions This is a paradigm shift study as for the first time this large population‐based study in adults showed that asthma status has a profound effect on the ARIA classification. Rhinitis alone and rhinitis with asthma represent two distinct phenotypes. These results reinforce the need to include asthma status in the ARIA classification and guidelines.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Maritta S. Jaakkola

-

FINLAND
View details

Iana Markevych

Research group leader

Jagiellonian University

POLAND
View details

Julia Dratva

Co-head of institute

ZHAW Zürcher Hochschule für Angewandte Wissenschaften

SWITZERLAND
View details

Annabelle Bédard

Université Paris-Saclay

FRANCE
View details

Amandine Divaret-Chauveau

University Hospital of Nancy

FRANCE
View details

Judith Garcia Aymerich

Research Professor and Head of the Non-Communicable Diseases and Environment Programme

Instituto de Salud Global Barcelona

SPAIN
View details

nicolas roche

-

FRANCE
View details

Andre F. S. Amaral

Imperial College London

UNITED KINGDOM
View details

Caroline Lodge

University of Melbourne

AUSTRALIA
View details

José Antonio Gullón

Profesor asociado

University of Oviedo

SPAIN
View details

Rachel Nadif

Senior researcher, member of the Integrative Respiratory Epidemiology team

INSERM

FRANCE
View details

Danielle Vienneau

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Elaine Fuertes

Epidemiologist

Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit

GERMANY
View details

Joachim Heinrich

-

AUSTRALIA
View details

Jouni J. K. Jaakkola

University of Oulu

FINLAND
View details

Mathias Holm

University of Gothenburg

SWEDEN
View details

Nicole Le Moual

INSERM

FRANCE
View details

Marie Aline Charles

Research Director

Université Paris Descartes

FRANCE
View details